With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global ...

Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

(AP) — Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the Indianapolis ... 58.8 billion in revenue. Eli Lilly and Co. shares ...

(Reuters) -Eli Lilly on Thursday ... but has been subdued since October when Lilly reported disappointing sales for its highly in-demand treatments. The Indianapolis-based drugmaker reported ...

FILE - A sign for Eli Lilly & Co. appears outside their corporate headquarters in Indianapolis on April 26, 2017. Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling ...

Eli Lilly’s profit doubled in the fourth quarter ... States as a treatment for some forms of sleep apnea. For 2025, the Indianapolis drugmaker expects adjusted earnings to range between $ ...